QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 21:54 UTC · Public disclosure record

CHKPTICKER

Check Point Software Technologies Ltd.

VERY BULLISH stock

Congress has disclosed 11 buys and 16 sells of CHKP (Check Point Software Technologies Ltd.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

11
Buy
16
Sell
-5
Net
11
Active politicians

Round-trip watch Still on the books

Members who disclosed buying CHKP and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Alan Armstrong 2026-03-30 $141.20 $152.11 +7.7% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2025 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
15.2
▼ cheaper than Technology (median 33.7)
how it's calculated
P/E = price ÷ earnings per share
$152.11 ÷ $10.01 = 15.2
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
5.57
▼ cheaper than Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$152.11 ÷ $27.29 = 5.57
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
16.66
▼ cheaper than Technology (median 21.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($16.1B − $1.8B net cash) ÷ $0.9B = $14.3B ÷ $0.9B = 16.66
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 7022 Mystic Alerts Act Science, Technology, Communications 2026-10-22
S 5663 PROOF Act Science, Technology, Communications 2026-09-30
SRES 923 A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". Science, Technology, Communications 2026-09-29
HR 10610 Stop Spam Calls Act Science, Technology, Communications 2026-09-24
HR 10594 Reliable Artificial Intelligence Research Act of 2026 Science, Technology, Communications 2026-09-24

27 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Thomas Kean House SELL ◆ insider convergence Self · Kean Family Partnership 2026-06-01 1 days +0.7% $1K–$15K
0.1% of NW
33.1 ↗ filing
Thomas Kean House SELL ◆ insider convergence Self · Kean Family Partnership 2026-06-01 30 days -3.4% $1K–$15K
0.1% of NW
33.1 ↗ filing
Alan Armstrong Senate BUY Self 2026-03-30 113 days -7.6% $1K–$15K 83.3 ↗ eFD
Thomas Kean House BUY Self · Kean Family Partnership 2025-08-04 29 days -1.3% $1K–$15K
0.1% of NW
62.9 ↗ filing
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2022-05-10 29 days — $1K–$15K
<0.1% of NW
8.6 ↗ filing
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2022-05-09 30 days — $1K–$15K
<0.1% of NW
10.6 ↗ filing
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2022-05-06 33 days — $1K–$15K
<0.1% of NW
15.7 ↗ filing
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2022-05-05 34 days — $1K–$15K
<0.1% of NW
22.3 ↗ filing
Peter Meijer House SELL Self 2021-02-17 2 days — $15K–$50K 56.6 ↗ filing
Peter Meijer House BUY Self 2021-01-26 8 days — $1K–$15K 75.9 ↗ filing
Greg Gianforte House SELL Joint 2020-03-30 7 days — $50K–$100K 66.8 ↗ filing
Josh Gottheimer House SELL Joint 2020-03-26 12 days — $1K–$15K
<0.1% of NW
52.4 ↗ filing
Greg Gianforte House SELL Joint 2020-01-13 8 days — $15K–$50K 90.8 ↗ filing
Donna Shalala House BUY Self 2019-02-15 13 days — $1K–$15K 75.9 ↗ filing
Katherine Clark House SELL Spouse 2018-10-01 48 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Pete Sessions House SELL Spouse 2017-12-07 0 days — $15K–$50K
0.9% of NW
28.8 ↗ filing
Josh Gottheimer House BUY Joint 2017-02-21 533 days — $1K–$15K
<0.1% of NW
75.9 ↗ filing
Katherine Clark House BUY Spouse 2016-10-11 197 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Susan Davis House SELL Spouse 2016-08-25 5 days — $15K–$50K 56.6 ↗ filing
Pete Sessions House SELL Spouse 2016-06-14 0 days — $1K–$15K
0.2% of NW
26.5 ↗ filing
Alan Lowenthal House SELL Spouse 2016-05-25 7 days — $1K–$15K 52.4 ↗ filing
Alan Lowenthal House BUY Spouse 2016-01-19 3 days — $1K–$15K 75.9 ↗ filing
Pete Sessions House BUY Spouse 2015-08-25 0 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Pete Sessions House BUY Spouse 2015-08-21 0 days — $15K–$50K
0.9% of NW
56.6 ↗ filing
Pete Sessions House BUY Spouse 2015-05-06 1 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Susan Davis House BUY Self 2015-03-31 7 days — $15K–$50K 90.8 ↗ filing
Thomas MacArthur House SELL Joint 2015-01-27 5 days — $15K–$50K 90.8 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CHKP — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

2
Congress trades with insider convergence
0
…with insider divergence
8
Insider open-market trades

Of the congressional trades in CHKP, 2 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-10-22 Kremer Nataly C-suite SELL 10b5-1 $478K ↗ EDGAR
2026-08-04 Seddik Sherif C-suite SELL 10b5-1 $1.3M ↗ EDGAR
2026-08-03 Golan Roei C-suite SELL 10b5-1 $51K ↗ EDGAR
2026-08-03 Golan Roei C-suite SELL 10b5-1 $1.2M ↗ EDGAR
2026-08-03 Kremer Nataly C-suite SELL $82K ↗ EDGAR
2026-06-11 UNGERMAN JERRY T Director SELL 10b5-1 $3.1M ↗ EDGAR
2026-06-11 Shavit Shenhav Tal Director SELL 10b5-1 $3.1M ↗ EDGAR
2026-06-02 Chelouche Yoav Director SELL 10b5-1 $3.5M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-10-22 Kremer Nataly C-suite 10b5-1 SELL $478K
◆ insider 2026-08-04 Seddik Sherif C-suite 10b5-1 SELL $1.3M
◆ insider 2026-08-03 Golan Roei C-suite 10b5-1 SELL $51K
◆ insider 2026-08-03 Golan Roei C-suite 10b5-1 SELL $1.2M
◆ insider 2026-08-03 Kremer Nataly C-suite SELL $82K
◆ insider 2026-06-11 UNGERMAN JERRY T Director 10b5-1 SELL $3.1M
◆ insider 2026-06-11 Shavit Shenhav Tal Director 10b5-1 SELL $3.1M
◆ insider 2026-06-02 Chelouche Yoav Director 10b5-1 SELL $3.5M
Congress 2026-06-01 Thomas Kean SELL $1K–$15K
Congress 2026-06-01 Thomas Kean SELL $1K–$15K
Congress 2026-03-30 Alan Armstrong BUY $1K–$15K
Congress 2025-08-04 Thomas Kean BUY $1K–$15K
Congress 2022-05-10 Josh Gottheimer SELL $1K–$15K
Congress 2022-05-09 Josh Gottheimer SELL $1K–$15K
Congress 2022-05-06 Josh Gottheimer SELL $1K–$15K
Congress 2022-05-05 Josh Gottheimer SELL $1K–$15K
Congress 2021-02-17 Peter Meijer SELL $15K–$50K
Congress 2021-01-26 Peter Meijer BUY $1K–$15K
Congress 2020-03-30 Greg Gianforte SELL $50K–$100K
Congress 2020-03-26 Josh Gottheimer SELL $1K–$15K
Congress 2020-01-13 Greg Gianforte SELL $15K–$50K
Congress 2019-02-15 Donna Shalala BUY $1K–$15K
Congress 2018-10-01 Katherine Clark SELL $1K–$15K
Congress 2017-12-07 Pete Sessions SELL $15K–$50K

FAQ Common questions

How much has Congress traded CHKP?

11 disclosed buys and 16 sells of CHKP (Check Point Software Technologies Ltd.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CHKP?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.